199 related articles for article (PubMed ID: 2111977)
1. Interferon gamma therapy for cutaneous leishmaniasis.
Kürkçüoğlu N; Tandoğdu R
Arch Dermatol; 1990 Jun; 126(6):831-2. PubMed ID: 2111977
[No Abstract] [Full Text] [Related]
2. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
Belazzoug S; Neal RA
Trans R Soc Trop Med Hyg; 1986; 80(4):670-1. PubMed ID: 3544363
[No Abstract] [Full Text] [Related]
3. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
[No Abstract] [Full Text] [Related]
4. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
Navin TR; Arana BA; Arana FE; de Mérida AM; Castillo AL; Pozuelos JL
Am J Trop Med Hyg; 1990 Jan; 42(1):43-50. PubMed ID: 2405727
[TBL] [Abstract][Full Text] [Related]
5. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR
Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
[TBL] [Abstract][Full Text] [Related]
6. Diffuse cutaneous leishmaniasis acquired in Peru.
Franke ED; Lucas CM; Tovar AA; Kruger JH; De Rivera MV; Wignall FS
Am J Trop Med Hyg; 1990 Sep; 43(3):260-2. PubMed ID: 2221221
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
Netto EM; Marsden PD; Llanos-Cuentas EA; Costa JM; Cuba CC; Barreto AC; Badaró R; Johnson WD; Jones TC
Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171
[TBL] [Abstract][Full Text] [Related]
8. Treatment of kala azar.
Ozsoylu S
Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
[No Abstract] [Full Text] [Related]
9. Recurrences of tegumentary leishmaniasis.
Weigle KA; Valderrama L; Santrich C; Saravia NG
Lancet; 1985 Sep; 2(8454):557-8. PubMed ID: 2863579
[No Abstract] [Full Text] [Related]
10. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
Costa JM; Marsden PD
Rev Soc Bras Med Trop; 1988; 21(2):85-6. PubMed ID: 3249826
[No Abstract] [Full Text] [Related]
11. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
12. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
Carrió J; Portús M
BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027
[TBL] [Abstract][Full Text] [Related]
13. Old-world leishmaniasis of the auricle.
Skevas A; Kastanioudakis I; Bai M; Kostoula A
Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123
[No Abstract] [Full Text] [Related]
14. Retention of antimony in hair during leishmaniasis treatment.
Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
[No Abstract] [Full Text] [Related]
15. [Leishmaniasis caused by Leishmania viannia braziliensis (Lvb). A case of atypical course].
Costa JM; Vale KC; França F; Lago EL; Magalhães AV; Marsden PD; Sampaio RN
Rev Soc Bras Med Trop; 1988; 21(2):71-3. PubMed ID: 2854901
[No Abstract] [Full Text] [Related]
16. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
Firooz A; Khamesipour A; Ghoorchi MH; Nassiri-Kashani M; Eskandari SE; Khatami A; Hooshmand B; Gorouhi F; Rashighi-Firoozabadi M; Dowlati Y
Arch Dermatol; 2006 Dec; 142(12):1575-9. PubMed ID: 17178983
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous leishmaniasis].
Vion B
Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
[No Abstract] [Full Text] [Related]
18. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
[No Abstract] [Full Text] [Related]
19. Cutaneous leishmaniasis in French Guiana: a review.
Dedet JP
Am J Trop Med Hyg; 1990 Jul; 43(1):25-8. PubMed ID: 2200289
[TBL] [Abstract][Full Text] [Related]
20. [Torsades de pointes during treatment of leishmaniasis with meglumine antimoniate].
Castelló Viguer MT; Echánove Errazti I; Ridocci Soriano F; Esteban Esteban E; Atienza Fernández F; Cuesta Estellés G
Rev Esp Cardiol; 1999 Jul; 52(7):533-5. PubMed ID: 10439681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
